Next week on the stock market
We don’t support this browser anymore. This means our website may not look and work as you would expect. Read more about browsers and how to update them here.
Newsroom
Newsroom articles are published by leading news agencies. Hargreaves Lansdown is not responsible for an article's content and its accuracy. We may not share the views of the author.
HL Podcast
HL Insight
Archived article Tax, investments and pension rules can change over time so the information below may not be current. This article was correct at the time of publishing, however, it may no longer reflect our views on this topic.
What to expect from a selection of FTSE 100, FTSE 250 and selected other companies reporting next week.
This article isn’t personal advice. If you’re not sure whether an investment is right for you please seek advice. If you choose to invest the value of your investment will rise and fall, so you could get back less than you put in.
21 July 2023
What to expect from a selection of FTSE 100, FTSE 250 and selected other companies reporting next week:
If you'd like to receive weekly shares content from us, sign up to our share insight email.
*Events on which we will be updating investors.
At GSK’s half-year health check, we’ll be watching out for any changes to 2023 sales growth guidance which currently stands between 6% to 8% for non-COVID 19 medicines. This underpins targeted dividend pay-outs of 56.5p per share in the current financial year, a yield of about 4%. That’s an extra demand on the Company’s cash resources, so we’ll also be looking to see if the group can return to generating free cash flow following an outflow in the first quarter.
Recent months have seen some important milestones in the group’s vaccine
Read more on hl.co.uk
